In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol

@article{Tauscher1999InV1,
  title={In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol},
  author={J. Tauscher and B. K{\"u}fferle and S. Asenbaum and P. Fischer and L. Pezawas and C. Barnas and S. Tauscher-Wisniewski and T. Bruecke and S. Kasper},
  journal={Psychopharmacology},
  year={1999},
  volume={141},
  pages={175-181}
}
  • J. Tauscher, B. Küfferle, +6 authors S. Kasper
  • Published 1999
  • Medicine, Psychology
  • Psychopharmacology
  • Abstract We investigated the degree of striatal dopamine-2 (D2) receptor occupancy in six schizophrenic patients receiving clinically effective antipsychotic treatment with olanzapine 10–25 mg/day in comparison to patients treated with clozapine 300–600 mg/day (n = 6) or haloperidol 5–20 mg/day (n = 10). 123I Iodobenzamide (IBZM) and single photon emission computerized tomography (SPECT) were used for the visualization of striatal D2 receptors. For the quantification of striatal D2 receptor… CONTINUE READING
    D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study
    32
    Cerebral D2 and 5-HT2 Receptor occupancy in Schizophrenic Patients Treated with Olanzapine Or Clozapine
    30

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 29 REFERENCES
    Sertindole and dopamine D2 receptor occupancy in comparison to risperidone, clozapine and haloperidol – a 123I-IBZM SPECT study
    50
    Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.
    484
    Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders
    153